Cargando…
Pharmacogenomics of GPCR Drug Targets
Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is an underappreciated burden on public health. Although 108 G-protein-coupled receptors (GPCRs) are the targets of 475 (∼34%) Food and Drug Administration (FDA)-approved drugs and acco...
Autores principales: | Hauser, Alexander S., Chavali, Sreenivas, Masuho, Ikuo, Jahn, Leonie J., Martemyanov, Kirill A., Gloriam, David E., Babu, M. Madan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766829/ https://www.ncbi.nlm.nih.gov/pubmed/29249361 http://dx.doi.org/10.1016/j.cell.2017.11.033 |
Ejemplares similares
-
Molecular Deconvolution Platform to Establish Disease Mechanisms by Surveying GPCR Signaling
por: Masuho, Ikuo, et al.
Publicado: (2018) -
A Global Map of G Protein Signaling Regulation by RGS Proteins
por: Masuho, Ikuo, et al.
Publicado: (2020) -
GPCR activation mechanisms across classes and macro/microscales
por: Hauser, Alexander S., et al.
Publicado: (2021) -
Novel approaches leading towards peptide GPCR de‐orphanisation
por: Hauser, Alexander S., et al.
Publicado: (2020) -
Common coupling map advances GPCR-G protein selectivity
por: Hauser, Alexander S, et al.
Publicado: (2022)